Given the complexity of controlled substance regulations, organizations must take a proactive approach to compliance and ...

In order to acquire Hillrom in late 2021, Baxter increased leverage substantially. On a net leverage basis, Baxter expanded its pro forma leverage from only 1 times as of June 2021 to the low 4s after ...

Vadodara: Alembic Pharma, an Indian multinational pharmaceutical company, has announced that the Company has received an ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Vadodara: Alembic Pharma, an Indian multinational pharmaceutical company, has announced that the Company has commissioned a ...

Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") - Update on USFDA inspection at API ...

President Donald Trump has threatened tariffs on pharmaceutical imports, with U.S. Commerce Secretary Howard Lutnick confirming that the tariffs will be implemented “in a month or two,” ABC ...

The costs are staggering. Building a new pharmaceutical facility in the US can cost upwards of USD 2 billion, according to Pharmaceutical Research and Manufacturers of America (PhRMA). “Even with a ...

Credit: Piotr Swat/Shutterstock. Kyowa Kirin has completed the construction of its new drug substance (DS) manufacturing facility, the HB7 building, at its Takasaki plant in Japan. Investment in the ...

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug conjugates for the treatment of cancer. Boehringer Ingelheim announced the official ...